Is all Cold Plasma created equal?
There is no doubt a wide variety of Cold Plasma medical devices currently on the market and new Cold Plasma designs often being released by startup companies. But how do these devices compare in efficacy, strength, reliability, and performance?
To say all Cold Plasmas are the same, which some companies (shockingly) do, would be farfetched and misleading. This is like comparing a race between a sports car and a bicycle or saying all liquids or gases are the same – the product and plasma components are technically very different.
When Adtec first developed Cold Plasma and carried out the first ever clinical trials on wounds many years ago, our data showed the remarkably strong and reputable results that we still deliver today. This is exclusively for our range of Adtec Cold Plasma medical devices. Our data is often cited by other Cold Plasma companies as their own medical devices lack strength in efficacy and performance in clinical data.
The important questions to raise are:
- What is the frequency of Cold Plasma applications per week to achieve full healing?
- How deep can the Cold Plasma penetrate?
- How quick can the Cold Plasma be applied?
- What is the delivery method of Cold Plasma?
- Is Cold Plasma limited to acute and superficial wounds or can it treat deep, chronic wounds with biofilm?
- What is the clinical evidence for the product itself and not cold plasma in general?
Whilst there are some Cold Plasma medical devices that do not satisfy the requirements met by a wound clinician, the SteriPlas does remain the leader and favorable choice in the Cold Plasma medical market. A once per week treatment time of 2 minutes per 12cm2 has been shown to accelerate healing in chronic, problematic, and non-healing wounds with biofilm presence. This cannot be said for all other Cold Plasma devices which recommend treatment once per day and are only indicated for acute, small, and superficial wounds certainly with no biofilm presence.
Due to its overall larger size which houses crucial components ensuring a consistent, reliable and therapeutic Cold Plasma, the SteriPlas is the only microwave-energy, Cold Argon Plasma medical device which delivers deep, dense and rich Cold Plasma able to kill all bacterial species embedded within biofilm. We can boast that no side effects have been reported with our Cold Plasma medical device since the history of its making.
For more information about the SteriPlas and how we have changed the way that wounds are healed, please visit our page: https://adtechealthcare.com/cold-plasma-wound-treatment/
Why Bigger is Better?
The SteriPlas has been widely documented in clinical trials and publications for its strong antibacterial efficacy and accelerated healing properties. Being the first medical device worldwide to show just how effective Cold Plasma can be from clinical trials on wounds, it is still the only medical device covering a larger 12cm2 treatment area using microwave-energy, safe, reputable, and consistent Cold Plasma. It is also the only medical device that can treat wounds within this size for only 2 minutes to achieve antibiofilm efficacy with no reported side effects.
So how does it compare to a Cold Plasma Pen?
As useful as Plasma pens can be for very small and superficial wounds without biofilm, 2 minutes is required for the treatment area equivalent to a few mms.
This means to treat a large and deep wound that the SteriPlas can do in 2 minutes (hands-free), then Plasma Pens would require in excess of 30 minutes with handheld use to reduce the bacterial load present in the same wound area . The SteriPlas is the only medical device with antibiofilm efficacy due to its dense and deep penetration capabilities making it the leader in Cold Plasma medicine.
Adtec to present at the Advanced Wound Care Summit EU
We’ve been invited to speak at the Advanced Wound Care Summit EU conference in London this week. Our Senior Business Development Manager, Jeiram, will be part of the Executive Speakers Line Up at the opening session “Panel Prioritising Clinical Data & Health Economic Evidence” at 8.55am on Tuesday 28th November.
Adtec Healthcare strives for strong and reputable clinical evidence. Over the years of our existence, we have collected a total of 80+ peer reviewed clinical studies on the SteriPlas Premium Cold Plasma which has resulted in quality Health Economics data for our medical device.
We understand the absolute importance of Health Economics data to back the claims of medical devices. With our clinical evidence, we can present the promising results of the SteriPlas for significantly accelerating wounds stalled with biofilm and reducing bed occupancy, antibiotics usage and the financial burden posed on hospitals.
Day 4 of Medica
Day 4 of the MEDICA Trade Fair.
As the show comes to a close, we would like to thank everyone who has visited our booth. An enormous presence of Medical Distributors who have come to our booth specifically to partner with us knowing our Premium Cold Plasma technology has the leading efficacy has been very much welcomed.
You can still reach us at info@adtecplasma.com or visit our website: www.adtechealthcare.com
Safe travels for everyone going home!
80 Peer-reviewed Clinical Studies
Can the SteriPlas:
Kill all forms of bacteria? YES ✔
Kill bacteria protected within biofilm? YES ✔
Operate safely with no side effects? YES ✔
Treat infected wounds in as quick as 2 minutes? YES ✔
Ready to learn more? Visit our website: https://adtechealthcare.com/cold-plasma-wound-treatment/
Our 80 peer-reviewed clinical trials and publications illustrate why our SteriPlas remains the leader for Cold Plasma with anti-biofilm efficacy
#medicaldistributor #MEDICA2023 #ABHI #Plasma #investorswanted #investor
Day 3 of Medica
Day 3 of the MEDICA Trade Fair. We're on booth J60.3, Hall 16 ready to welcome you to our booth and show exactly how Premium Cold Plasma is revolutionising the way patients with chronic wounds are being fully healed even if they have heavy biofilm presence.
Sitting at the forefront of the Cold Plasma market
There's a reason why we're the leaders of Cold Plasma.
Adtec Healthcare Ltd has been at the forefront of Cold Plasma by having the most experience on the market. We have invested years of gathering strong clinical evidence all the way from being the first company worldwide to introduce Cold Plasma on wounds in clinical trials many years ago to having our medical device widely adopted in hospitals across the UK and Europe.
The SteriPlas is the only Cold Plasma medical device with anti-biofilm efficacy by having dense, rich, microwave-driven Cold Plasma. No side effects have been reported with the use of our medical device.
To learn about the #mythbusting on Cold Plasma visit our webpage: https://adtechealthcare.com/cold-plasma-wound-treatment/
#MEDICA2023 #ABHI #ABHI2023 #Medicaldistributor #Investors
Day 2 of Medica
Our presentation today was met with much success.
The SteriPlas has proven antibacterial efficacy for the treatment of chronic wounds, surgical site infections and medical dermatology. If you would like to learn more, please visit our booth J60 in Hall 16 during the MEDICA-TradeFair.
Day 1 of Medica
Day 1 of the MEDICA Trade Fair was a success. Interacting with many distributors and clinicians with positive interest in our promising Premium Cold Plasma. We encourage you to visit our booth again today to see why the SteriPlas is revolutionising the global wound care market.
Don't forget to attend our presentation today from 11:55 - 12:15 at the ABHI stand. We will be presenting the strong clinical evidence of the SteriPlas Premium Cold Plasma used for wounds, Surgical Site Infections and medical dermatology in the UK Theatre in Hall 16, J48.
Adtec Healthcare to present at the Medica 2023 Trade Fair
Don't forget to attend our presentation during the MEDICA Trade Fair on Tuesday 16th November from 11:55 - 12:15. We will be presenting the strong clinical evidence of the SteriPlas Premium Cold Plasma used for chronic wounds, surgical site infections and medical dermatology in the UK Theatre in Hall 16, J48.